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strongly that it is necessary to
maintain a strong commitment to
the detailed analysis of cellular
processes.
What do you think about the
state of research in France? I
am rather concerned. France has
the financial and human
resources to carry on highly
competitive research, yet it
needs a major overhaul of its
current system. I would like to
convince the Government to
invest much more and for a
longer time in basic science —
applied research won’t be
effective if not supported by
strong academic research. And I
would like to convince many of
my colleagues who are unhappy
with the present situation that we
need changes, to embrace what
is working elsewhere: primarily a
granting agency, local
independence, good contracts
for postdocs. In many ways, the
centralised organisation and
culture of the country is impeding
the development of biology,
which does not naturally operate
on the same (big) scale as
physics. Life science labs have
their own particular needs and
constraints compared to other
branches of science, so
organisational rules devised for
other sciences may hinder
progress and efficiency in biology
if rigidly applied (and vice versa
of course).
....and in Europe? Again, a
granting agency that funds
projects from individual labs is
essential; it does not mean that
the funding of networks should
necessarily be dropped, but that
these should be made much less
artificial. The EMBO has recently
launched a training program to
foster the organisational skills —
grant writing, conflict
management, PhD student
supervision and so forth — of
principal investigators receiving
the ‘young investigator program’
(YIP) award. This is a welcome
initiative, which the EU should
extend.
IGBMC, 1 rue Laurent Fries, BP10142,
67404 ILLKIRCH CEDEX, France.
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Also known as... Protein
phosphatase 2B (PP2B) and
occasionally Ca2+–calmodulin-
activated protein phosphatase.
Only the Human Genome
Organization nomenclature
committee calls it PP3.
What is it and what does it do?
Calcineurin is a phosphoprotein
serine/threonine phosphatase,
activated physiologically by
Ca2+–calmodulin. In plain
language, calcineurin couples
intracellular Ca2+ to
dephosphorylation of selected
substrates. The biological
consequences are diverse and
depend on the cellular context.
Thus, in mammals, calcineurin
contributes to regulation of
enzymes and ion channels,
chemotaxis and neuronal growth
cone pathfinding, membrane
vesicle trafficking, development of
cardiac valves and osteoclasts,
and genetic programs of
activation in lymphocytes and
differentiation in skeletal muscle.
What does it look like?
Calcineurin is a dimer of an A
catalytic subunit and a B subunit
(Figure 1). Calmodulin becomes
tightly associated with calcineurin
only in the presence of elevated,
but physiological, levels of Ca2+.
In mammals three isoforms of
calcineurin A (Aα, Aβ, Aγ) and two
isoforms of calcineurin B (B1, B2)
are expressed from separate
genes.
Where can it be found?
Calcineurin is present in all
eukaryotes investigated except
higher plants. It is found in all
tissues in mammals, with notably
high levels in brain. Calcineurin
can have a pivotal role in
intracellular signalling even at
relatively low levels, however, as
exemplified in T lymphocytes and
skeletal muscle. In budding yeast,
calcineurin has a role in
coordinating adaptation to
environmental stress both through
the calcineurin–Crz1p
transcriptional pathway and
through post-translational
mechanisms. 
What are its substrates?
Substrates that contribute to
transcriptional signalling, in
particular nuclear factor of
activated T cells (NFAT), have
sometimes overshadowed
calcineurin’s substrates in non-
transcriptional pathways, which
constitute a vast majority of the
identified substrates. Substrate
selection is determined in part by
a docking site in calcineurin that
recognizes the consensus PxIxIT
motif in NFAT and some other
substrates. Since not all
Figure 1. Ribbon diagram
of the calcineurin A (red)–
calcineurin B (green)
dimer from PDB entry
1AUI, with the
autoinhibitory peptide
blocking access to the
bound Fe2+ and Zn2+
(small dark spheres) of
the catalytic site. A region
of calcineurin A whose
structure has not been
determined is indicated
schematically (grey).
Calmodulin (yellow), on
activation by Ca2+, binds
to its target sequence in
calcineurin A and induces
a structural change that
relieves autoinhibition. The structure of the Ca2+–calmodulin–calcineurin A complex
has not been solved, and therefore the structure illustrated is based on the complex
of calmodulin with a cognate peptide. The Ca2+-binding sites of calcineurin B and
calmodulin are shown occupied (large dark spheres). The PxIxIT substrate recognition
site is accessible in resting and activated calcineurin.
substrates depend on binding at
this site, there are probably
additional substrate recognition
sites. Another contribution to
substrate selection is made by
scaffold proteins, e.g. AKAP79,
which target the phosphatase to
neuronal synapses or other
cellular sites. Calcineurin also
delegates work to protein
phosphatase 1 (PP1) through a
phosphatase cascade, in which
dephosphorylation of the PP1
antagonists DARPP-32 or
inhibitor-1 by calcineurin relieves
their inhibitory effect on PP1, and
allows PP1 to act on its own
preferred substrates.
What are its inhibitors?
Cyclosporin A (CsA) and FK506
bind tightly to the abundant
intracellular proteins cyclophilin A
and FKBP12, respectively, and
the resulting ligand–protein
complex binds to calcineurin and
impedes access of protein
substrates to the active site.
Blockade of a biological process
by CsA and independently by
FK506 is diagnostic for
calcineurin involvement. Other
inhibitors that find frequent
experimental use are the
autoinhibitory peptide from
calcineurin and fragments of the
regulatory proteins
DSCR1/MCIP/calcipressin/Rcn1p,
Cabin1/cain, and AKAP79.
Does it have any medical
relevance? Calcineurin signalling
is prominent in transplant
rejection and autoimmune
disease, where the inhibitors CsA
and FK506 are used clinically, and
is being studied for its
contribution to myocardial
hypertrophy and to virulence in
fungal pathogens.
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Mangrove forests have iconic
status as natural ecosystems that
provide services to humans. They
function as breeding, spawning,
hatching and nursing grounds for
marine and pelagic species, and
are important in the daily
livelihood of local human
subsistence communities.
Mangrove representatives such as
Rhizophora spp. also function as a
physical barrier against tidal and
ocean influences by means of
their large above-ground aerial
root systems and standing crop.
Like many habitats, mangrove
forests have been degraded and
destroyed by humans, and their
loss is a source of global concern.
In the second half of the 20th
century, 50% of the world’s
mangrove forests have been
destroyed, and current annual
loss rates vary from 1 to 20% [1].
Ironically, the great human
tragedy of the recent December
26th tsunami may provide the
stimulus for a better
understanding of what mangrove
forests can and cannot do for
human well-being.
Essay
How effective were mangroves as a 
defence against the recent tsunami?
Whether or not mangroves function as buffers against tsunamis is the
subject of in-depth research, the importance of which has been
neglected or underestimated before the recent killer tsunami struck. Our
preliminary post-tsunami surveys of Sri Lankan mangrove sites with
different degrees of degradation indicate that human activity
exacerbated the damage inflicted on the coastal zone by the tsunami.
Figure 1. Dendrogram generated by a cluster analysis of the 24 mangrove sites
investigated, indicating their characteristics and the impact of the tsunami (big wave,
severely impacted; small wave, little impacted).
The ‘mangrove status’ is a combination of pre-tsunami aerial extent of the front man-
grove and pre-tsunami mangrove destruction (see text). The tsunami had only a small
impact on lagoons that show no cryptic ecological degradation (sites 2, 3, 23 and 24)
or that are protected by the distance from the shore and by frontal Rhizophora spp.
fringes (sites 17, 18 and 21). The lagoons are numbered clockwise from East to West,
to emphasize that damage was not linked to geographic position in view of tsunami
wave energy. A map overview of all lagoons can be found in Jayatissa et al. [18], with
the exception of Batticaloa, Komari and Potuvil, which are located at the easternmost
extremity of the island. L, Lagoon; E, Estuary.
6. 
8.
9.
11.
12.
20.
18.
17.
21. 
1.
7.
13.
14.
15.
16.
19.
4.
5.
9.
22.
23.
24.
2.
3.
Walawey Ganga E.
Kahandamodara L.
Rekawa L.
Dickwella
Talalla L.
Akurala
Galle-Unawatuna
Koggala L.
Balapitiya E. 
Batticaloa L.
Kalametiya L.
Devinuwara L.
Nilwala Ganga E.
Polwatumodara
Kapparatota
Ginganga E.
Palatupana L.
Kirinda L.
Kirama Oya mouth
Kosgoda
Bentota Ganga E.
Kaluwamodara
Komari L.
Pottuvil L.
60 70 80
Similarity
90 100
Cryptic
ecological
degradation
No
cryptic
ecological
degradation
Bad pre-tsunami
mangrove status
Relatively good pre-tsunami
mangrove status
Relatively good pre-tsunami
mangrove status
Current Biology
